{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:03:28Z","timestamp":1780401808331,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI37618"],"award-info":[{"award-number":["R01 AI37618"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.molmed.2004.03.006","type":"journal-article","created":{"date-parts":[[2004,4,10]],"date-time":"2004-04-10T07:53:41Z","timestamp":1081583621000},"page":"226-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Mutations in CD46, a complement regulatory protein, predispose to atypical HUS"],"prefix":"10.1016","volume":"10","author":[{"given":"Timothy H.J.","family":"Goodship","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.Kathryn","family":"Liszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2004.03.006_BIB1","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to Von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2004.03.006_BIB2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2004.03.006_BIB3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1086\/318203","article-title":"Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition","volume":"68","author":"Richards","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2004.03.006_BIB4","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","article-title":"Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome","volume":"100","author":"Richards","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2004.03.006_BIB5","first-page":"407","article-title":"Haemolytic uraemic syndrome","volume":"Vol. 4","author":"Warwicker","year":"2003"},{"key":"10.1016\/j.molmed.2004.03.006_BIB6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2004.03.006_BIB7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/jmg.40.9.676","article-title":"Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries","volume":"40","author":"Neumann","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molmed.2004.03.006_BIB8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0272-6386(12)80449-5","article-title":"Inherited hemolytic uremic syndrome in adults","volume":"19","author":"Berns","year":"1992","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.molmed.2004.03.006_BIB9","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJM197505222922102","article-title":"Hemolytic uremic syndrome in families","volume":"292","author":"Kaplan","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2004.03.006_BIB10","first-page":"213","article-title":"Hemolytic uremic syndrome in families","author":"Kaplan","year":"1992"},{"key":"10.1016\/j.molmed.2004.03.006_BIB11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic haemolytic uraemic syndrome","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2004.03.006_BIB12","first-page":"110","article-title":"Hypocomplementaemia due to a genetic deficiency of beta-1H globulin","volume":"46","author":"Thompson","year":"1981","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF00858631","article-title":"Recurrent hemolytic uremic syndrome and acquired hypomorphic variant of the third component of complement","volume":"4","author":"Roodhooft","year":"1990","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB14","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0272-6386(12)81065-1","article-title":"Familial hemolytic-uremic syndrome and homozygous factor-H deficiency","volume":"24","author":"Pichette","year":"1994","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.molmed.2004.03.006_BIB15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s004670050515","article-title":"Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H - Original article","volume":"12","author":"Ohali","year":"1998","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB16","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1034\/j.1600-065X.2001.1800113.x","article-title":"Structure and flexibility of the multiple domain proteins that regulate complement activation","volume":"180","author":"Kirkitadze","year":"2001","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2004.03.006_BIB17","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/302673","article-title":"Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome","volume":"65","author":"Ying","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2004.03.006_BIB18","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1086\/302877","article-title":"Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome","volume":"66","author":"Buddles","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2004.03.006_BIB19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1681\/ASN.V122297","article-title":"The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20","volume":"12","author":"Caprioli","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB20","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/318201","article-title":"Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome","volume":"68","author":"P\u00e9rez-Caballero","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2004.03.006_BIB21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/jmbi.2001.5337","article-title":"Molecular modelling of the C-terminal domains of factor H of human complement. A correlation between haemolytic uraemic syndrome and a predicted heparin binding site","volume":"316","author":"Perkins","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB22","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome","volume":"111","author":"Manuelian","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2004.03.006_BIB23","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.4049\/jimmunol.169.9.4702","article-title":"Cutting edge: localization of the host recognition functions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome","volume":"169","author":"Pangburn","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB24","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/344515","article-title":"Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome","volume":"71","author":"Sanchez-Corral","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2004.03.006_BIB25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2249.1993.tb05998.x","article-title":"Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues","volume":"94","author":"Endoh","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ki.1994.247","article-title":"Localization of the complement regulatory proteins in the normal human kidney","volume":"46","author":"Ichida","year":"1994","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2004.03.006_BIB27","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI114196","article-title":"Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells","volume":"84","author":"McNearney","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2004.03.006_BIB28","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/eji.1830240711","article-title":"Identification and characterization of membrane cofactor protein (CD46) in the human kidneys","volume":"24","author":"Nakanishi","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB29","first-page":"341","article-title":"Identification and quantification of complement regulator CD46 on normal human tissues","volume":"79","author":"Johnstone","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.molmed.2004.03.006_BIB30","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.4049\/jimmunol.168.12.6298","article-title":"Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells","volume":"168","author":"Barilla-LaBarca","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<815::AID-IMMU815>3.0.CO;2-8","article-title":"Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation","volume":"29","author":"Devaux","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB32","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.4049\/jimmunol.151.3.1519","article-title":"Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis","volume":"151","author":"Kojima","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB33","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.175.6.1547","article-title":"Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism","volume":"175","author":"Oglesby","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2004.03.006_BIB34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/bj2640581","article-title":"Functional properties of membrane cofactor protein of complement","volume":"264","author":"Seya","year":"1989","journal-title":"Biochem. J."},{"key":"10.1016\/j.molmed.2004.03.006_BIB35","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1084\/jem.163.4.837","article-title":"Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b","volume":"163","author":"Seya","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2004.03.006_BIB36","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1073\/pnas.82.3.859","article-title":"Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines","volume":"82","author":"Cole","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2004.03.006_BIB37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0065-2776(08)60868-8","article-title":"Control of the complement system","volume":"61","author":"Liszewski","year":"1996","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1084\/jem.174.1.93","article-title":"Membrane cofactor protein of the complement system: alternative splicing of serine\/threonine\/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype","volume":"174","author":"Post","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2004.03.006_BIB39","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/eji.1830220625","article-title":"Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing","volume":"22","author":"Russell","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB40","unstructured":"Riley-Vargus, R.C. and Atkinson, J.P. (2004) Expression of membrane cofactor protein (MCP; CD46) on spermatozoa: Just a complement inhibitor? Modern Aspects of Immunobiology (in press)."},{"key":"10.1016\/j.molmed.2004.03.006_BIB41","series-title":"Membrane Defenses Against Attack by Complement and Perforins","author":"Parker","year":"1992"},{"key":"10.1016\/j.molmed.2004.03.006_BIB42","series-title":"Complement Regulatory Proteins","author":"Morgan","year":"1999"},{"key":"10.1016\/j.molmed.2004.03.006_BIB43","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.4049\/jimmunol.165.7.3999","article-title":"Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack","volume":"165","author":"Brodbeck","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB44","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.4049\/jimmunol.147.9.3005","article-title":"Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity","volume":"147","author":"Adams","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB45","doi-asserted-by":"crossref","first-page":"37692","DOI":"10.1074\/jbc.M004650200","article-title":"Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46)","volume":"275","author":"Liszewski","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2004.03.006_BIB46","doi-asserted-by":"crossref","first-page":"9183","DOI":"10.1128\/JVI.77.17.9183-9191.2003","article-title":"Adenovirus type 11 uses CD46 as a cellular receptor","volume":"77","author":"Segerman","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB47","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/nm952","article-title":"CD46 is a cellular receptor for group B adenoviruses","volume":"9","author":"Gaggar","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2004.03.006_BIB48","first-page":"250","article-title":"Hemolytic uremic syndrome in three adult siblings: a family study and evolution","volume":"28","author":"Pirson","year":"1987","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB49","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0140-6736(03)14742-3","article-title":"Familial haemolytic uraemic syndrome and an MCP mutation","volume":"362","author":"Noris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2004.03.006_BIB50","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1046\/j.1523-1755.1998.00943.x","article-title":"Endothelial cell activation","volume":"53","author":"Ballermann","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2004.03.006_BIB51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1034\/j.1600-065X.2001.1800116.x","article-title":"Targeting complement in therapy","volume":"180","author":"Kirschfink","year":"2001","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2004.03.006_BIB52","series-title":"Therapeutic Interventions in the Complement System","author":"Lambris","year":"2002"},{"key":"10.1016\/j.molmed.2004.03.006_BIB53","first-page":"168","article-title":"The complement system in hemolytic\u2013uremic syndrome","volume":"13","author":"Monnens","year":"1980","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.molmed.2004.03.006_BIB54","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(73)92782-7","article-title":"Serum-complement levels in haemolytic uremic syndrome","volume":"2","author":"Kaplan","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2004.03.006_BIB55","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0140-6736(98)01267-7","article-title":"Escherichia coli O157:H7","volume":"352","author":"Mead","year":"1998","journal-title":"Lancet"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491404000796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491404000796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:14:12Z","timestamp":1761462852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491404000796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S1471491404000796"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2004.03.006","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutations in CD46, a complement regulatory protein, predispose to atypical HUS","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2004.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}